D-745-2014 Class III Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-745-2014 was initiated by Pfizer Inc. on Jan 2, 2014 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Pfizer is recalling certain lots due to out of specification results for azithromycin N-oxide degradant. The recall status is terminated (terminated Mar 14, 2016). Affected quantity: 101,681 Vials.

Recall details

Product Type
Drugs
Report Date
Jan 22, 2014
Initiation Date
Jan 2, 2014
Termination Date
Mar 14, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
101,681 Vials

Product description

Zithromax (azithromycin for injection), 500 mg/vial, Sterile, Rx Only, For I.V. infusion only, No latex, No preservative, Made in Ireland, Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017, NDC 0069-3150-84

Reason for recall

Failed Impurities/Degradation Specifications: Pfizer is recalling certain lots due to out of specification results for azithromycin N-oxide degradant.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot Number/Expiration Date G81845, Exp 10/03/14 0B0CJ, Exp 02/06/15 G44710, Exp 07/10/15 G65241, Exp 07/11/15 G80003, Exp 10/17/15 G82722, Exp 11/27/15 G93028, G95309, Exp: 01/23/16 G97641, Exp 01/30/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-745-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-745-2014. Report a data issue: hello@regdatalab.com.